Treatment of Symptomatic Uterine Fibroids with Ulipristal Acetate: Endometrial Safety

被引：0
|
作者：
Catherino, William
Eisenhut, Carol
Blakesley, Rick
Chan, Anna
Sniukiene, Vilma
Goldstein, Steven
机构：
[1] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[2] DCL Pathol, Indianapolis, IN USA
[3] Allergen Plc, Jersey City, NJ USA
[4] NYU, Sch Med, New York, NY USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1121
引用
收藏
页码：279A / 279A
页数：1
相关论文
共 50 条
  • [1] Treatment of Symptomatic Uterine Fibroids with Ulipristal Acetate: Endometrial Safety
    Catherino, William
    Eisenhut, Carol
    Blakesley, Rick
    Chan, Anna
    Sniukiene, Vilma
    Goldstein, Steven
    LABORATORY INVESTIGATION, 2017, 97 : 279A - 279A
  • [2] ENDOMETRIAL SAFETY OF ULIPRISTAL ACETATE TREATMENT FOR SYMPTOMATIC UTERINE FIBROIDS IN PREMENOPAUSAL WOMEN - A SYSTEMATIC REVIEW
    Ples, Liana
    Carp, Delia
    Sima, Romina Marina
    Mirica, Alexandra
    Stanescu, Anca-Daniela
    Balalau, Denisa-Oana
    Balalau, Cristian
    FARMACIA, 2018, 66 (05) : 763 - 769
  • [3] Assessment of Endometrial Safety During Treatment of Symptomatic Uterine Fibroids With Ulipristal Acetate: VENUS II
    Eisenhut, Carol
    Smith, Donald
    Mallick, Madhuja
    Chan, Anna
    Sniukiene, Vilma
    Goldstein, Steven
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S74 - S74
  • [4] Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids
    Karly P. Garnock-Jones
    Sean T. Duggan
    Drugs, 2017, 77 : 1665 - 1675
  • [5] Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids
    Garnock-Jones, Karly P.
    Duggan, Sean T.
    DRUGS, 2017, 77 (15) : 1665 - 1675
  • [6] Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids
    Semmler, Annika
    de Lange, Maria E.
    Drenth, Joost P. H.
    Vermeer, Niels S.
    Bet, Pierre M.
    Huirne, Judith A. F.
    Hehenkamp, Wouter J. K.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2025, 21 : 367 - 382
  • [7] Effects of ulipristal acetate in patients with symptomatic uterine fibroids
    Navarro Plazaola, Natalia
    Vega Chacana, Marla
    Aviles Dorlhiac, Raimundo
    MEDWAVE, 2021, 21 (04):
  • [8] Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids
    Tafi, Emanuela
    Scala, Carolina
    Maggiore, Umberto Leone Roberti
    Bizzarri, Nicolo
    Candiani, Massimo
    Venturini, Pier Luigi
    Ferrero, Simone
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (06) : 965 - 977
  • [9] Series of 55 pregnancies following ulipristal acetate treatment of symptomatic uterine fibroids
    Costa, Ana R.
    Carvalho, Ana P.
    Martins, Diana R.
    Carvalho, Maria J.
    Silva, Pedro T.
    Roque, Silvia C.
    Silva, Daniel P.
    JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS, 2020, 12 (3-4) : 170 - 175
  • [10] Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids
    Tuschy, Benjamin
    Gabbert, Mirja
    Weiss, Christel
    Hornemann, Amadeus
    Wuhrer, Anne
    Suetterlin, Marc
    Berlit, Sebastian
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 228 : 106 - 110
12345